☆ 4.7 Article

The Spectrum of Acute Cerebrovascular Disease in Patients with COVID-19

BIOMEDICINES (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pharmacology & Pharmacy

Thromboinflammation in coronavirus disease 2019: The clot thickens

Raayma Iffah et al.

Summary: The pathophysiology of COVID-19 is complex, with multiple systems contributing to thrombosis and inflammation. Understanding the role of the immune system in different patient cohorts is crucial for developing novel therapeutic targets and drug repurposing strategies.

BRITISH JOURNAL OF PHARMACOLOGY (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective

Azita Hajhossein Talasaz et al.

Summary: COVID-19, caused by SARS-CoV-2, has been declared a pandemic by the World Health Organization. While there is no approved therapy yet, medications such as hydroxychloroquine, remdesivir, dexamethasone, protease inhibitors, and anti-inflammatory agents are being used globally in the treatment of SARS-CoV-2 infection.

CARDIOVASCULAR DRUGS AND THERAPY (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Cardiovascular risk factors, cardiovascular disease, and COVID-19: an umbrella review of systematic reviews

Stephanie L. Harrison et al.

Summary: An umbrella review of systematic reviews on COVID-19 showed that various cardiovascular risk factors are associated with the severity and mortality of the disease. Many of these modifiable risk factors can be targeted by primary and secondary prevention strategies aiming to improve outcomes for individuals post COVID-19.

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES (2021)

添加到收藏夹

Review Neuroimaging

Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist

Amanda Zakeri et al.

Summary: COVID-19 is caused by SARS-CoV-2, leading to arterial thrombosis in some patients. This review provides a brief overview of the disease, the mechanisms of COVID-19-associated coagulopathy, and the impact of COVID-19 on ischemic stroke.

JOURNAL OF NEUROINTERVENTIONAL SURGERY (2021)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation

Sean X. Gu et al.

Summary: Platelet and endothelial dysfunction are essential components of COVID-19 pathology, while cardiovascular risk factors exacerbate the severity of the disease. Patients with pre-existing cardiovascular disease and risk factors are at the highest risk of death from COVID-19.

NATURE REVIEWS CARDIOLOGY (2021)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association

Salim S. Virani et al.

Summary: The American Heart Association, in partnership with the National Institutes of Health, publishes annual statistics on heart disease, stroke, and cardiovascular risk factors, including the impact of health behaviors and factors on cardiovascular health. The Statistical Update covers a range of clinical heart and circulatory conditions, providing data on quality of care, procedures, and economic costs. It serves as a critical resource for various stakeholders seeking the best available data on these factors and conditions.

CIRCULATION (2021)

添加到收藏夹

Article Clinical Neurology

Acute Ischemic Stroke and COVID-19 An Analysis of 27 676 Patients

Adnan Qureshi et al.

Summary: Acute ischemic stroke is rare in patients with COVID-19 and is usually accompanied by other cardiovascular risk factors. The risk of discharge to a destination other than home or death doubles with the occurrence of acute ischemic stroke in patients with COVID-19.

STROKE (2021)

添加到收藏夹

Review Environmental Sciences

Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective

Francesco Fisicaro et al.

Summary: The current research on the neuropathology of COVID-19 deceased patients is still limited, focusing on vascular-related and infection-related inflammatory tissue damage. However, it is currently unclear whether these findings are the result of direct viral pathology or the non-specific impact of cardiovascular and pulmonary diseases on the brain.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

添加到收藏夹

Review Clinical Neurology

Stroke Care during the COVID-19 Pandemic: International Expert Panel Review

Narayanaswamy Venketasubramanian et al.

Summary: The COVID-19 pandemic has posed challenges for stroke management, with clinicians facing various etiologies for stroke compounded by unique complications associated with the virus. Strict infection control measures and continuous medical care are essential throughout the patient care journey.

CEREBROVASCULAR DISEASES (2021)

添加到收藏夹

Article Medicine, General & Internal

Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19-A Report for the GCS-NeuroCOVID Consortium and the ENERGY Consortium

Sherry H. -Y. Chou et al.

Summary: This study included patients with clinically diagnosed or laboratory-confirmed COVID-19 at 28 centers across 13 countries and 4 continents from March 1 to September 30, 2020. Neurological manifestations were prevalent among hospitalized patients with COVID-19 and were associated with higher in-hospital mortality. Patients with preexisting neurological disorders were at increased risk of developing neurological signs and/or syndromes in COVID-19.

JAMA NETWORK OPEN (2021)

添加到收藏夹

Article Clinical Neurology

Treatment and Outcomes of Patients With Ischemic Stroke During COVID-19 An Analysis From Get With The Guidelines-Stroke

Pratyaksh K. Srivastava et al.

Summary: This study analyzed the characteristics, treatment, and outcomes of acute ischemic stroke patients before and during the COVID-19 pandemic. While stroke presentations decreased during COVID-19, the treatment and in-hospital outcomes remained similar to pre-COVID-19 levels.

STROKE (2021)

添加到收藏夹

Article Microbiology

Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease

Hernan F. Penaloza et al.

Summary: COVID-19 is caused by SARS-CoV-2 virus, with neutralizing antibodies and T cell responses being crucial for effective immunity. Neutrophils play a significant role in the pathophysiology of the disease.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Medicine, General & Internal

Atrial Fibrillation and Clinical Outcomes in a Cohort of Hospitalized Patients with Sars-Cov-2 Infection and Chronic Kidney Disease

Simonetta Genovesi et al.

Summary: This study found that chronic kidney disease has an impact on in-hospital mortality and incident atrial fibrillation in patients with SARS-CoV-2 infection. The occurrence of acute kidney injury is also an important factor.

JOURNAL OF CLINICAL MEDICINE (2021)

添加到收藏夹

Review Medicine, General & Internal

Elevated Procalcitonin Is Positively Associated with the Severity of COVID-19: A Meta-Analysis Based on 10 Cohort Studies

Yue Shen et al.

Summary: This meta-analysis found that patients with elevated procalcitonin levels upon admission are more likely to develop severe COVID-19, with the association remaining even after adjusting for diabetes but weakening. The study suggests that procalcitonin may serve as a potential biomarker for evaluating the severity of COVID-19 and predicting prognosis.

MEDICINA-LITHUANIA (2021)

添加到收藏夹

Review Clinical Neurology

Stroke in COVID-19: A systematic review and meta-analysis

Stefania Nannoni et al.

Summary: Acute cerebrovascular diseases occur in 1.4% of COVID-19 patients, with acute ischemic stroke being the most common manifestation. Patients with COVID-19 are more likely to have pre-existing vascular risk factors and higher mortality rates compared to those without cerebrovascular diseases.

INTERNATIONAL JOURNAL OF STROKE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Altered COVID-19 receptor ACE2 expression in a higher risk group for cerebrovascular disease and ischemic stroke

Ji-Young Choi et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)

添加到收藏夹

Review Clinical Neurology

Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms

Zhiqiang Zhou et al.

JOURNAL OF NEUROLOGY (2020)

添加到收藏夹

Letter Clinical Neurology

Characteristics of ischaemic stroke associated with COVID-19

Rahma Beyrouti et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

添加到收藏夹

Article Clinical Neurology

Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China

Ling Mao et al.

JAMA NEUROLOGY (2020)

添加到收藏夹

Letter Medicine, General & Internal

Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young

Thomas J. Oxley et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications

James D. McFadyen et al.

CIRCULATION RESEARCH (2020)

添加到收藏夹

Article Clinical Neurology

Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description

Francisco Hernandez-Fernandez et al.

BRAIN (2020)

添加到收藏夹

Article Infectious Diseases

Procalcitonin levels in COVID-19 patients

Rui Hu et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms

Manuela Pennisi et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

添加到收藏夹

Article Clinical Neurology

Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study

Yanan Li et al.

STROKE AND VASCULAR NEUROLOGY (2020)

添加到收藏夹

Letter Clinical Neurology

Thrombotic Neurovascular Disease in COVID-19 Patients

Ahmad Sweid et al.

NEUROSURGERY (2020)

添加到收藏夹

Article Clinical Neurology

Characteristics and Outcomes in Patients With COVID-19 and Acute Ischemic Stroke The Global COVID-19 Stroke Registry

George Ntaios et al.

STROKE (2020)

添加到收藏夹

Review Clinical Neurology

COVID-19 and cerebrovascular diseases: a comprehensive overview

Georgios Tsivgoulis et al.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2020)

添加到收藏夹

Review Radiology, Nuclear Medicine & Medical Imaging

Neuroradiologic manifestations of COVID-19: what the emergency radiologist needs to know

Michael F. Goldberg et al.

EMERGENCY RADIOLOGY (2020)

添加到收藏夹

Review Immunology

The trinity of COVID-19: immunity, inflammation and intervention

Matthew Zirui Tay et al.

NATURE REVIEWS IMMUNOLOGY (2020)

添加到收藏夹

Review Clinical Neurology

Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series

Sujan T. Reddy et al.

CASE REPORTS IN NEUROLOGY (2020)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.